NeoGenomics(NEO) - 2025 Q1 - Quarterly Results

Fort Myers, Florida (April 29, 2025) - NeoGenomics, Inc. (NASDAQ: NEO) (the "Company"), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced its first-quarter results for the period ended March 31, 2025. Exhibit 99.1 NeoGenomics Reports First Quarter 2025 Results Consolidated Revenue Increased 8% to $168 million First Quarter 2025 Highlights As Compared To First Quarter 2024 "Our business is off to a solid start in 2025 with our team delivering a record number ...